Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Dose faible And NotWolfgang Wuttke

List of bibliographic references

Number of relevant bibliographic references: 11.
Ident.Authors (with country if any)Title
000335 Twice-Daily, Low-Dose Pramipexole in Early Parkinson's Disease: A Randomized, Placebo-Controlled Trial
000619 Richard A. Walsh [Canada] ; Anthony E. Lang [Canada]Early-Onset Tardive Dyskinesia in a Neuroleptic-Naive Patient Exposed to Low-Dose Quetiapine
001928 Angelo Antonini [Italie] ; Silvana Tesei [Italie] ; Anna Zecchinelli [Italie] ; Paolo Barone [Italie] ; Danilo De Gaspari [Italie] ; Margherita Canesi [Italie] ; Giorgio Sacilotto [Italie] ; Nicoletta Meucci [Italie] ; Claudio Mariani [Italie] ; Gianni Pezzoli [Italie]Randomized study of sertraline and low-dose amitriptyline in patients with Parkinson's disease and depression : Effect on quality of life
002414 Hubert H. Fernandez [États-Unis] ; Martha E. Trieschmann [États-Unis] ; Monica A. Burke [États-Unis] ; Carol Jacques [États-Unis] ; Joseph H. Friedman [États-Unis]Long-term outcome of quetiapine use for psychosis among parkinsonian patients
002514 Nancy Belanger [Canada] ; Laurent Gregoire [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; Paul J. Bedard [Canada]Chronic treatment with small doses of cabergoline prevents Dopa-induced dyskinesias in Parkinsonian monkeys
002629 Padraig O'Suilleabhain [États-Unis] ; Richard B. Jr Dewey [États-Unis]Randomized trial comparing primidone initiation schedules for treating essential tremor
002672 William G. Ondo [États-Unis] ; Joel K. Levy [États-Unis] ; Kevin Dat Vuong [États-Unis] ; Christine Hunter [États-Unis] ; Joseph Jankovic [États-Unis]Olanzapine treatment for dopaminergic-induced hallucinations
002708 Petr Kanovsky [République tchèque] ; Dagmar Kubova [République tchèque] ; Martin Bares [République tchèque] ; Hana Hortova [République tchèque] ; Hana Streitova [République tchèque] ; Ivan Rektor [République tchèque] ; Vladimir Znojil [République tchèque]Levodopa-induced dyskinesias and continuous subcutaneous infusions of apomorphine: Results of a two-year, prospective follow-up
003129 F. Lobbezoo [Canada] ; G. J. Lavigne [Canada] ; R. Tanguay [Canada] ; J. Y. Montplaisir [Canada]The effect of the catecholamine precursor L-dopa on sleep bruxism : A controlled clinical trial
003161 G. Meco [Italie] ; A. Alessandri [Italie] ; P. Giustini [Italie] ; V. Bonifati [Italie]Risperidone in levodopa-induced psychosis in advanced Parkinson's disease: An open-label, long-term study
003570 J. P. Jr Bennett [États-Unis] ; E. R. Landow ; S. Dietrich ; L. A. SchuhSuppression of dyskinesias in advanced Parkinson's disease: moderate daily clozapine doses provide long-term dyskinesia reduction

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024